重药控股：2025年上半年净利润同比增长18.56%

Group 1 - The company reported a revenue of 41.188 billion yuan for the first half of 2025, representing a year-on-year growth of 3.54% [1] - The net profit for the same period was 282 million yuan, showing an increase of 18.56% compared to the previous year [1]